InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
65,000
$62.06
$4.03M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
61,652
$60.08
$3.70M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
43,348
$59.26
$2.57M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
2,449
$61.26
$150.03K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
10,072
$60.47
$609.05K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
12,479
$59.50
$742.50K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,515
$60.49
$1.30M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
31,694
$59.88
$1.90M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,791
$58.81
$1.28M
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
2,062
$44.93
$92.65K
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
37,938
$44.40
$1.68M
Show all 30 transactions →

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 11
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 402,491
History held since 6 Nov 2014